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Mitochondrial reactive oxygen species promote p65
nuclear translocation mediating high-phosphate-
induced vascular calcification in vitro and in vivo
Ming-Ming Zhao1,2, Ming-Jiang Xu1,2, Yan Cai1, Gexin Zhao1, Youfei Guan1, Wei Kong1, Chaoshu Tang1
and Xian Wang1
1Department of Physiology and Pathophysiology, School of Basic Medical Science, Peking University Health Science Center,
Key Laboratory of Molecular Cardiovascular Science, Ministry of Education, Beijing, People’s Republic of China
Hyperphosphatemia is the major risk factor associated
with vascular calcification (VC) in end-stage renal disease.
As oxidative stress is increased in uremia, we studied the role
of mitochondrial reactive oxygen species (ROS) and nuclear
factor-jB signaling in phosphate-induced VC. In an in vitro
calcification model (b-glycerophosphate (BGP) induction)
using bovine aortic smooth muscle cells, the production of
intracellular and mitochondrial ROS, or superoxide anion,
was stimulated by increased mitochondrial membrane
potential. This effect was blocked by the superoxide
dismutase (SOD) mimic MnTMPyP, a respiratory chain
inhibitor rotenone, or a protonophore. Calcium deposition
and the switch of smooth muscle cells from a contractile to
an osteogenic phenotype were decreased when
mitochondrial ROS generation was inhibited by the
respiratory chain inhibitor, MnTMPyP, or the overexpression
of SOD1 and SOD2 and uncoupling protein 2. The
phosphorylation of IkKb, IjBa degradation, and p65 nuclear
translocation were increased by BGP but reversed when
mitochondrial ROS production was blocked by protonophore
or MnTMPyP. Knockdown of endogenous p65 or
overexpression of IjBa reduced calcium deposition in the
cultured cells. Furthermore, in a rat model of dietary adenine-
induced chronic renal failure, MnTMPyP reduced aortic ROS
levels, p65 activation, and calcium deposition. Thus,
mitochondrial ROS-mediated p65 nuclear translocation is
involved in phosphate-induced VC.
Kidney International (2011) 79, 1071–1079; doi:10.1038/ki.2011.18;
published online 2 March 2011
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Vascular calcification (VC) is a major risk factor for
cardiovascular mortality, particularly in patients with end-
stage renal disease (ESRD)1–4 and diabetes.5 VC may develop
in two distinct layers of the artery: the tunica intima and
tunica media. Intima calcification occurs in advanced
atherosclerotic lesions. Media calcification develops indepen-
dently of atherosclerosis and is mainly associated with aging,
diabetes, and ESRD. Calcification in the tunica media is
generally believed to develop analogous to intramembranous
osteogenesis. It now appears also to involve endochondral
bone formation, because the expression of osteogenic trans-
cription factor core-binding factor a-1 (Cbfa1) and chon-
drocyte-specific markers has been reported in the calcified
media of uremic patients and animal arteries.6–9 Accumulated
data have suggested that vascular smooth muscle cells
(VSMCs) transdifferentiate into osteogenic cells, produce
mineralized matrix, and express osteogenic proteins, thus
contributing to VC.8,10,11
Hyperphosphatemia, manifested during chronic renal fail-
ure (CRF) and subsequent dialysis in which serum inorganic
phosphate (Pi) levels typically exceed 2mmol/l,12,13 is highly
associated with the extent of VC and contributes directly to
high morbidity and mortality in vascular disease.13,14 Many
in vitro studies have implicated Pi as a key regulator of VC.15,16
Despite intensive investigation of the underlying mechanisms,
including napi-III transporter-mediated Pi uptake, increased
expression of Cbfa1, and subsequent elaboration of a pro-
mineralizing matrix,15 one critical issue of the link between
the level of intracellular Pi and Pi-induced osteogenic gene
expression remains to be elucidated.
Pi is one of the substrates for adenosine-50-triphosphate
synthesis during oxidative phosphorylation and also has an
important role in regulating mitochondrial membrane
potential (MP) and reactive oxygen species (ROS) produc-
tion in isolated mitochondria.17 In addition, several studies
have reported that uremia results in increased oxidative
stress,18 and oxidative stress is related to VC in vitro.19 Thus,
we hypothesized that Pi-induced mitochondrial oxidative
stress is essential for Pi-induced VC. We aimed to examine
a mitochondrial ROS–nuclear factor-kB (ROS–NF-kB)
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signaling pathway by which Pi promotes VC in bovine
aorta smooth muscle cells (BASMCs) and a dietary adenine-
induced rat CRF model.
RESULTS
b-Glycerophosphate (BGP) promoted BASMC calcification
To explore the potential mechanisms involved in media
calcification, we introduced a widely used cell model by
treating BASMCs with BGP (10mmol/l). The 45Ca2þ
incorporation rate was increased 100-fold with BGP treat-
ment for 2 days (Figure 1a), and calcium deposition was
enhanced B300-fold (Figure 1b). As well, BGP treat-
ment significantly stimulated calcium nodule formation, as
revealed by alizarin red staining (Figure 1c). Accordingly,
real-time PCR revealed that the mRNA levels of bone-related
molecules, Cbfa1 and msh homeobox 2 (Msx2), were
increased, whereas that of the smooth muscle cell (SMC)
lineage markers, SM-a-actin and SM22a, were significantly
decreased with BGP treatment for 7 days (Figure 1d). The
protein levels of SM-a-actin, SM22a, and Cbfa1 were
similarly altered (Figure 1e).
BGP promoted ROS production in BASMCs
To test whether BGP can directly increase ROS production in
cultured BASMCs, we used several specific ROS probes
to detect BGP-induced ROS levels. As shown in Figure 2a,
luminol chemiluminescence detected the generation of
intracellular H2O2 immediately enhanced B2.5-fold in both
normal cultured and BGP-pretreated BASMCs with BGP
(10mmol/l) administration for 2 days. This overproduction
of H2O2 was sustained until a superoxide dismutase (SOD)
mimic MnTMPyP was added. Because mitochondria are one
of the main sources of ROS generation, we then detected
BGP-induced mitochondrial ROS production by a specific
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Figure 1 | b-Glycerophosphate (BGP) promoted smooth muscle cell (SMC) calcification and phenotypic transition. (a) Bovine aorta
smooth muscle cells (BASMCs) were treated with BGP (10mmol/l) for 2 days, and 45Ca2þ incorporation rate was measured. (b) BASMCs were
cultured in medium with (BGP group) or without BGP (Ctrl group) for 7 days; calcium content in the cells was assayed, and data were
normalized by total protein. (c) After treatment with BGP for 7 days, calcium deposition in BASMCs was assessed by alizarin red staining; one
representative image of three independent experiments is shown. (d) Real-time PCR analysis of mRNA levels of bone-related molecules
(core-binding factor a1 (Cbfa1) and msh homeobox 2 (Msx2)) and SMC lineage markers (a-actin and SM22a) in BASMCs treated with BGP for
7 days. (e) Western blot analysis of protein levels of a-actin, SM22a, and Cbfa1; b-actin was a control for protein loading. For the bar graphs,
data from 4 to 5 independent experiments were included for statistical analysis, *Po0.05 vs control (Ctrl). CPM, counts per minute.
1072 Kidney International (2011) 79, 1071–1079
or ig ina l a r t i c l e M-M Zhao et al.: ROS–NF-jB signaling mediates vascular calcification
probe as described in the Materials and Methods. As shown
in Figure 2b, BGP significantly enhanced mitochondrial ROS
generation approximately threefold. Because the original
form of ROS generating from mitochondria was O2
 , we
next measured mitochondrial O2
  level by a specific probe,
mitochondrial circularly permuted yellow fluorescent protein
(mt-cpYFP). BGP caused approximately onefold increase in
mt-cpYFP fluorescence intensity (Figure 2c), and this increase
was completely inhibited by MnTMPyP treatment (Figure 2d).
These data indicate that BGP can immediately induce intra-
cellular and mitochondrial ROS production in BASMCs.
BGP induced ROS production by increasing mitochondrial MP
Because ROS production from the respiratory chain is related
to mitochondrial MP and high mitochondrial MP seems to
favor the production of ROS, particularly at complex III,20
we therefore detected the mitochondrial MP in response to
high-Pi treatment. BGP significantly increased mitochondrial
MP, as assessed by the fluorescence intensity of DiOC6(3),
which was blocked immediately by rotenone, an inhibitor
of respiratory chain complex I (Figure 3a), and CCCP
(carbonyl cyanide m-chlorophenyl hydrazone), an uncoupler
of oxidative phosphorylation (Figure 3b), but was not
affected by MnTMPyP (Figure 4c). When BASMCs were pre-
incubated with rotenone (10 mmol/l) or CCCP (10 mmol/l)
for 10min, BGP-enhanced production of mitochondrial
ROS (Figure 3d) or O2
  (Figure 3e) was circumvented. In
contrast, application of thenoyltrifluoroacetone (20 mmol/l),
an inhibitor of complex II, had no effect (data not shown).
Mitochondrial ROS are involved in BGP-induced BASMC
calcification
BGP increased mitochondrial ROS generation by enhancing
mitochondrial MP, but to date, no evidence indicates that
this ROS generation is directly involved in Pi-induced VSMC
calcification. Thus, we investigated the effects of various
reagents related to ROS generation and clearance on BGP-
induced VSMC calcification. Inhibitors of NADPH (nicoti-
namide adenine dinucleotide phosphate) oxidase (dipheny-
lene iodonium, 10 mmol/l), xanthine oxidase (allopurinol,
10 mmol/l), and adenosine-50-triphosphate synthase (oligo-
mycin, 10 mmol/l) had no effect on BGP-induced calcium
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Figure 2 | b-Glycerophosphate (BGP) promoted mitochondrial
reactive oxygen species (ROS) generation in bovine aorta
smooth muscle cells (BASMCs). (a) BASMCs under normal
culture or BGP treatment for 2 days were stimulated with BGP
(10mmol/l), and H2O2 generation was analyzed by luminol
chemiluminescence with superoxide dismutase mimic MnTMPyP
added. (b) Mitochondrial ROS was detected by MitoTracker Red
CM-H2XRos probe with confocal microscopy every 5 s.
(c) Mitochondrial O2
  was measured by the probe mitochondrial
circularly permuted yellow fluorescent protein (mt-cpYFP) with
confocal microscopy every 5 s. (d) Mitochondrial O2
  was
inhibited by MnTMPyP treatment (12.5 mmol/l). At least three
independent experiments were performed for each group.
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Figure 3 |Mitochondrial respiratory chain is the source
of b-glycerophosphate (BGP)-induced reactive oxygen species
(ROS) production. (a, b) BGP elevated the membrane potential,
as measured by the increased fluorescence intensity of DiOC6(3),
and was significantly reduced when respiratory chain inhibitor
rotenone (10 mmol/l) or carbonyl cyanide m-chlorophenyl
hydrazone (CCCP; 10 mmol/l) was added. (c) BGP-elevated
mitochondrial membrane potential was not affected by
MnTMPyP. BGP-increased (d) mitochondrial ROS and (e)
mitochondrial O2
  were attenuated by rotenone (10 mmol/l) and
CCCP (10mmol/l). At least three independent experiments were
performed for each group.
Kidney International (2011) 79, 1071–1079 1073
M-M Zhao et al.: ROS–NF-jB signaling mediates vascular calcification o r ig ina l a r t i c l e
deposition, whereas the SOD mimic MnTMPyP (12.5mmol/l)
and mitochondrial respiratory chain inhibitors rotenone and
CCCP (10 mmol/l) greatly reduced BGP-induced calcium
deposition, as assessed by calcium content assay (Figure 4a)
and alizarin red staining (data were not shown). In contrast,
genipin, an uncoupling protein 2 (UCP2) inhibitor, increased
BGP-induced calcium deposition (Figure 4a). To further
confirm the role of mitochondrial ROS in BASMC calcifica-
tion, we overexpressed SOD1, SOD2, and UCP2 by adeno-
viral vectors in BASMCs for 48 h before BGP stimulation,
and BGP-induced BASMC calcification was significantly
reduced by this overexpression (Figure 4b). These data
suggest that BGP-induced BASMC calcium deposition is
mainly via mitochondrial ROS.
Mitochondrial ROS mediated BGP-induced SMC phenotype
transition
Pi-induced VSMC calcification involves SMC phenotype
transition with loss of SMC lineage markers and expression
of osteogenic molecules.10 Therefore, we analyzed the effect
of mitochondrial ROS inhibitors on osteogenic transdiffer-
entiation of VSMCs. First, the expression of the BGP-induced
osteogenic genes Cbfa1 and Msx2 was markedly decreased
when cells were treated with rotenone, CCCP, or MnTMPyP,
but not with thenoyltrifluoroacetone (Figure 5a and b).
Correspondingly, BGP significantly decreased the expression
of the SMC lineage markers SM-a-actin and SM22a,
which was reversed by treatment with rotenone, CCCP, and
MnTMPyP, but not thenoyltrifluoroacetone (Figure 5c and d).
The effects of rotenone, CCCP, and MnTMPyP on inhibiting
osteogenic gene expression and rescuing SMC lineage
markers were further confirmed at the protein level (Figure
5e and f). Together with the effects of mitochondrial ROS
on BGP-induced calcium deposition, these data indicate a
critical role of mitochondrial ROS in BGP-induced VSMC
calcification.
NF-jB activation by mitochondrial ROS is essential for BGP-
induced VSMC calcification
To determine the downstream signaling of mitochondrial
ROS, we investigated the effects of BGP on the NF-kB
pathway. BGP increased IKKb phosphorylation and IkBa
degradation in a time-dependent manner (Figure 6a). The
BGP-induced degradation of IkBa was blocked by CCCP or
MnTMPyP (Figure 6b). In addition, the translocation of p65,
an NF-kB subunit, to the nucleus was markedly inhibited by
CCCP or MnTMPyP under BGP stimulation (Figure 6c).
Furthermore, p65-short hairpin RNA (shRNA) treatment to
knockdown the endogenous p65 level, when compared with
scramble shRNA, significantly decreased Pi-induced calcium
deposition in human SMCs, as assessed by alizarin red
staining and calcium content assay (Figure 6d). As well,
adenoviral overexpression of IkBa greatly reduced BGP-
induced calcium deposition in BASMCs (Figure 6e). These
results strongly indicate that mitochondrial ROS–NF-kB
signaling is involved in BGP-induced SMC calcification in
BASMCs.
SOD mimic attenuates VC in vivo
To further determine the role of ROS in Pi-induced VC
in vivo, we developed a rat CRF model (Table 1) by feeding
rats with dietary adenine (0.75%) for 6 weeks. Both CRF- and
MnTMPyP-treated rats showed equal body weight loss.
Serum Pi was increased approximately twofold in both
CRF- and MnTMPyP-treated rats (Table 1). Calcium
deposition in abdominal aortas, as assessed by von Kossa
staining and calcium content assay, was increased in CRF
rats. In contrast, calcium deposition was significantly
reversed in MnTMPyP-treated rats (Figure 7a and b).
Consistent with the in vitro observations, mitochondrial
ROS level was also increased in aortic walls from CRF rats
(Figure 7c) and was significantly attenuated with MnTMPyP
treatment. Immunofluorescence staining revealed that both
the phosphor-p65 level and nuclear translocation of phos-
phor-p65 increased in CRF rats but was inhibited with
MnTMPyP treatment (Figure 7d). Western blot analysis
revealed decreased IkBa protein level in CRF vascular tissue,
and MnTMPyP treatment could rescue the degradation of
IkBa (Figure 7e). These results indicate that the mitochon-
drial ROS–NF-kB pathway is involved in hyperphosphate-
mia-induced VC in CRF rats.
DISCUSSION
In this study, we demonstrate for the first time the
importance of ROS-mediated mitochondria-to-nucleus
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Figure 4 |Mitochondrion-derived reactive oxygen species
(ROS) mediated b-glycerophosphate (BGP)-induced smooth
muscle cell (SMC) calcification. Bovine aorta smooth muscle
cells (BASMCs) were cultured in medium with (BGP group) or
without BGP (Ctrl group) for 7 days. (a) BASMCs were treated with
BGP accompanied by the following inhibitors for 7 days:
diphenylene iodonium (DPI; 10 mmol/l), allopurinol (10 mmol/l),
oligomycin (10 mmol/l), MnTMPyP (12.5 mmol/l), rotenone (RO;
10mmol/l), CCCP (10mmol/l), thenoyltrifluoroacetone (TTFA;
10mmol/l), and genipin (100mmol/l) on BGP-induced calcium
deposits. (b) BASMCs were infected with adenovirus
(1¼ adenovirus expressing green fluorescent protein (GFP);
2¼ adenovirus expressing corresponding target genes as
indicated) for 2 days, and then treated with BGP for 7 days.
Calcium content was measured in cells overexpressing GFP,
superoxide dismutases 1 and 2 (SOD1, SOD2), or uncoupling
protein 2 (UCP2); n¼ 5, *Po0.05 vs Ctrl. #Po0.05 vs BGP or
GFPþ BGP.
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signaling in Pi-induced VC in vitro and in vivo. BGP
significantly increased mitochondrial MP and mitochondrial
ROS production, which in turn led to IkBa degradation and
p65 nuclear translocation, and ultimately contributed to VC.
Our data have revealed mitochondrial ROS as a novel
therapeutic target for prevention and treatment of VC.
Although oxidative stress has been linked to the
pathogenesis of hypercholesterolemia and dialysis-dependent
ESRD,18,21,22 no direct evidence or clearcut conclusions link
ROS level and cardiovascular complications in ESRD. Thus,
our data provide additional clues that ROS have a central role
in high Pi-induced VSMC calcification and hyperphos-
phatemia-induced VC in CRF rats, which is consistent with
and further extends results by Tepel et al.23 showing that
antioxidants can relieve vascular complications in patients
with chronic kidney disease. Furthermore, mitochondria are
the energy source in cells and, as a by-product of energy
production, also generate most of the endogenous ROS from
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Figure 5 |Mitochondrial reactive oxygen species (ROS) were involved in b-glycerophosphate (BGP)-induced smooth muscle cell
(SMC) phenotypic transition. Bovine aorta smooth muscle cells (BASMCs) were treated with BGP plus rotenone (RO), carbonyl cyanide
m-chlorophenyl hydrazone (CCCP), thenoyltrifluoroacetone (TTFA), or MnTMPyP for 7 days. Real-time PCR analysis of the mRNA levels of
(a, b) bone-related molecules core-binding factor a-1 (Cbfa1) and msh homeobox 2 (Msx2) and (c, d) SMC lineage markers a-actin and
SM22a. Bar graphs are representative of four independent experiments performed on four populations of cells. Results are relative to
b-actin level. (e) Western blot analysis of protein levels of SM22a, SM-a-actin, and Cbfa1. b-Actin was a control for protein loading.
Results are from one representative experiment of three. (f) Quantification of protein levels from western blot; data were normalized by
corresponding b-actin. *Po0.05 vs Ctrl. #Po0.05 vs BGP.
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the electron transport chain of cells.20 Our data indicate that
mitochondria are the major source of ROS production
mediating high-Pi-induced VSMC calcification by demon-
strating that: (1) Pi directly augmented mitochondrial O2
 
production by enhancing mitochondrial MP (Figure 3); (2)
antioxidants (MnTMPyP, SOD1, and SOD2) or inhibitors of
respiratory chain (rotenone, CCCP, and UCP2) can attenuate
Pi-induced ROS production and calcium deposition
(Figures 2–4); and (3) mitochondrial ROS are essential for
Pi-triggered phenotype switch of SMCs from a contractile to
an osteogenic phenotype (Figure 5).
In addition to mitochondrial production, ROS can be
produced by NADPH oxidase or xanthine oxidase. However,
our data show that the NADPH oxidase blocker diphenylene
iodonium and xanthine oxidase inhibitor allopurinol had no
effects on Pi-induced calcium deposition, which further
highlights the importance of mitochondrial-derived ROS in
Pi-induced VSMC calcification. Data from Sutra et al.24
suggested a major implication of vascular NADPH oxidase in
Pi-induced VC but not mitochondrial ROS. The main
difference between the two studies may be the cell type used.
The A7r5 cell line used by Sutra et al.24 are immortalized rat
aortic SMCs and may have a metabolic phenotype similar to
that of tumor cells, which are characterized by high glycolytic
rates and reduced mitochondrial oxidation, termed aerobic
glycolysis, and historically known as the Warburg effect.25
In contrast, we used primary cells from bovine aortas, which
metabolize glucose through the tricarboxylic acid cycle and
have much higher mitochondrial respiratory chain utilization.26
The next question needing resolution is which type of
ROS mediates the process we describe. Byon et al.19 reported
that H2O2 augmented Pi-induced mouse SMC calcification
by modulating the osteogenic transcription factor Cbfa1 via
AKT signaling. Here we found much less effect of exogenous
H2O2 on promoting calcification in BASMCs than in rodent
SMCs (Supplementary Figure S1 online). This finding may be
because of BGP stimulating the production of much more
endogenous ROS in BASMCs than in rodent SMCs (data
not shown), for less synergism of exogenous H2O2 and BGP
in promoting BASMC calcification. In our study, we used a
specific probe for mitochondrial O2
. and provided direct
evidence that O2
. has a predominant role in VSMC calcifi-
cation in vitro and in vivo. Even so, mitochondrial O2
. was
only a necessary condition, but not a sufficient condition for
Pi-induced VSMC calcification, because high glucose
(30mmol/l) itself could significantly increase mitochondrial
O2
. generation, but failed to induce VSMC calcification
without BGP (Supplementary Figure S2 online).
What is the potential signaling pathway mediating ROS
and VSMC calcification? Previous reports have shown that
oxidative stress can activate NF-kB,27 which mediated tumor
necrosis factor-a-augmented mesenchymal stem cell and
human SMC calcification through Msx2 expression.28,29 In
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Figure 6 |Nuclear factor-jB (NF-jB) activation by
mitochondrial reactive oxygen species (ROS) is essential for
b-glycerophosphate (BGP)-induced smooth muscle cell (SMC)
calcification. (a) Bovine aorta smooth muscle cells (BASMCs) were
stimulated with BGP for the indicated times. IKKb phosphorylation
and IkBa degradation were determined by western blot analysis.
(b) Western blot analysis of MnTMPyP and carbonyl cyanide
m-chlorophenyl hydrazone (CCCP) blocking BGP-induced IkBa
degradation. (c) Immunofluorescence analysis of p65 nuclear
translocation in BASMCs. BGP-induced p65 nuclear translocation
was prevented by pretreatment with MnTMPyP or CCCP. Results
are from one representative experiment of three. (d) Human aortic
SMCs were stably transfected with scramble short hairpin RNA
(shRNA) or p65-shRNA, and then treated with phosphate (Pi;
3.8mmol/l) for 10 days; western blot analysis of p65 protein level,
calcium content assay, and alizarin red staining assessment of
calcium deposition were performed; n¼ 4, *Po0.05 vs scramble
shRNA. (e) BASMCs overexpressed IkBa for 2 days, and then were
treated with BGP for 7 days; western blot analysis of IkBa protein
level and calcium content assay were performed; n¼ 5, *Po0.05
vs Ctrl. #Po0.05 vs green fluorescent protein (GFP)þ BGP. GAPDH,
glyceraldehyde-3-phosphate dehydrogenase.
Table 1 |Measurement of biochemical parameters in rat
serum and the mortality of the model
Control
(n=8)
CRF+Pi
(n=6)
CRF+ MnTMPyP
(n=6)
Pi (mmol/l) 2.73±0.10 5.50±0.36* 6.10±0.53*
Ca2+ (mmol/l) 2.65±0.04 2.55±0.05 2.76±0.17
BUN (mmol/l) 14.50±0.56 86.48±9.13* 91.38±6.38*
Cre (mmol/l) 89.00±6.14 322.00±10.99* 298.20±22.21*
Mortality (death/total) 0/8 2/8 0/6
Abbreviations: BUN, blood urea nitrogen; Cre, creatinine; CRF, chronic renal failure;
Pi, phosphate. *Po0.01 vs control.
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this study we demonstrate that activation of NF-kB is
essential for Pi-induced SMC calcification. This finding is
supported by Pi increasing IKKb phosphorylation and IkBa
degradation and promoting p65 nuclear translocation;
knocking down p65 by shRNA or overexpressing IkBa
significantly reduced Pi-induced calcium deposition in
BASMCs. We identify the nuclear translocation of the
NF-kB subunit p65 as downstream of mitochondrial ROS
by MnTMPyP and CCCP preventing IkBa degradation
and p65 nuclear translocation (Figure 6). Thus, activating
the mitochondrial O2
 –NF-kB pathway is necessary for
Pi-induced VC.
In conclusion, our results indicate a central role of
mitochondrial O2
  in VC of rats with CRF. Targeting the
mitochondrial O2
 –NF-kB pathway may pave the way for
clinical prevention and treatment of VC in patients with ESRD.
MATERIALS AND METHODS
Adenovirus preparation
The recombinant adenovirus carrying NF-kB inhibitor subunit-a
(IkBa) driven by a cytomegalovirus promoter was generously pro-
vided by Dr FH Bach (Harvard Medical School, Boston, MA). The
adenoviruses expressing SOD1, SOD2, and UCP2 were generously
provided by Dr MH Zou (Oklahoma University Health Science
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Figure 7 | Superoxide dismutase (SOD) mimic MnTMPyP attenuates vascular calcification in chronic renal failure (CRF) rats.
(a) von Kossa staining of abdominal aortas from control (Ctrl), adenine- (CRF), and MnTMPyP-treated CRF (CRFþMnTMPyP) rats.
(b) Abdominal aorta calcium content was measured by atomic absorption spectrometry. Data were normalized by dry tissue weight.
(c) Immunofluorescence analysis of mitochondrial reactive oxygen species (ROS) expression in cryosections of aortas from rats treated with
Ctrl, CRF, and CRFþMnTMPyP. (d) Immunofluorescence analysis of phosphorylated p65 and its nuclear translocation in aortic cryosections.
Results are from one representative experiment of three. (e) Western blot analysis of protein levels of IkBa in aortas. b-Actin was a control
for protein loading. (f) Summary of our main findings. MP, membrane potential; n¼ 6–8 rats, *Po0.05 vs Ctrl. #Po0.05 vs CRF.
Kidney International (2011) 79, 1071–1079 1077
M-M Zhao et al.: ROS–NF-jB signaling mediates vascular calcification o r ig ina l a r t i c l e
Center, Oklahoma City, OK). BASMCs were infected with corre-
sponding adenoviruses overnight in medium supplemented with
10% fetal bovine serum. The cells were then washed and incubated
in fresh medium for an additional 12 h before experimentation.
These conditions typically produced an infection efficiency of at
least 80%, as determined by green fluorescent protein expression.
Animal protocols
The CRF animal model was established as described previously.30 All
animals received humane care in compliance with the Institutional
Authority for Laboratory Animal Care of Peking University. The rat
CRF model was confirmed by increased serum creatinine, blood urea
nitrogen, and blood Pi levels in blood samples at the Peking University
Third Hospital using a HITACHI (Tokyo, Japan) 7170S instrument, as
shown in Table 1. Male Wistar rats, 8 weeks old, were pair-fed with
standard chow containing 1.2% calcium and 0.6% phosphorus for
the control group or 0.75% adenine and 0.9% phosphorus for the
CRF group. MnTMPyP (C44H36Cl5MnN8, 30 nmol/l per day per rat;
Calbiochem, Darmstadt, Germany) in phosphate-buffered saline
was given intraperitoneally for 6 weeks. After 6 weeks, the rats
were anesthetized with chloral hydrate, and blood was collected to
measure serum biochemical parameters. Abdominal aortas were
excised and fixed in 4% formaldehyde and sectioned for morpho-
logical analysis and von Kossa staining. For measurement of calcium
content, the abdominal aortas were dried and weighed, each sample
was extracted with 65% (W/W) HNO3 for 24 h at 200 1C to dissolve
the minerals, and the calcium content was measured by atomic
absorption spectrometry at 422.7 nm (Jena, novAA 300, Jena,
Germany). Results were normalized by dry tissue weight as we
described previously.11,31
Cell culture and cell calcification model
Human aortic SMCs transfected with scramble shRNA or p65-
shRNA were generously provided by Dr CY Wang (University of
California, Los Angeles, CA).
BASMCs were cultured as described.32,33 Briefly, segments of
aortas were obtained from prepubertal bovines. The inner portion
of the media was removed and cut into B1mm2 sections. The
sections were placed in a culture dish with Dulbecco’s modified
Eagle’s medium containing 4.5 g/l glucose supplemented with 20%
fetal bovine serum and 10mmol/l sodium pyruvate. Cells that had
migrated from the explants were collected and maintained in growth
medium (Dulbecco’s modified Eagle’s medium containing 15% fetal
bovine serum), and cells between passages 3 and 8 were used in the
experiments. For calcification experiments, cells were seeded at
1 104 cells/cm2 (day 0) and maintained in 15% fetal bovine serum/
Dulbecco’s modified Eagle’s medium until confluence (day 6), when
calcification was induced by adding 10mmol/l BGP (Sigma, St Louis,
MO). After 2 days, 45Ca2þ incorporation rate was measured as we
described.31 After 7 days of inducing calcification, calcium deposits
were detected by measuring calcium content or by alizarin red
staining as we described.11,31 For treatment of cells, antioxidants or
inhibitors, such as MnTMPyP, diphenylene iodonium, genipin,
CCCP, thenoyltrifluoroacetone, rotenone, allopurinol (Calbiochem),
were added with BGP every 3 days.
Chemiluminescence analysis
The generation of H2O2 was detected by luminol-plus-horseradish
peroxide-derived chemiluminescence using a BPCL Ultra-weak
luminescence analyzer (Beijing, China).34 Cells were maintained in
serum-free Dulbecco’s modified Eagle’s medium with 3U/ml
horseradish peroxide and 10mg/ml luminal (Sigma); BGP
(10mmol/l) and MnTMPyP were added as indicated, and the sum
counts reflected the generation of H2O2.
Mitochondrial ROS detection
MitoTracker Red CM-H2XRos probe (200nmol/l; Molecular Probes,
Eugene, OR) was used to detect mitochondrial ROS. Oxidant
quantification was based on the oxidation of MitoTracker Red
CM-H2XRos by mitochondrial ROS, which resulted in the formation
of the fluorescent compound. Fluorescence was monitored by confocal
laser scanning microscopy (Leica, Bannockburn, IL).
Mitochondrial O2
. detection
The biosensor for mitochondrial O2
 , cpYFP, was a gift from
Professor HP Cheng (Peking University, Beijing, China).35 The
fluorescence emission of purified cpYFP (at 515 nm) when excited
at 488 nm is 5 times brighter under strong oxidizing conditions
(1mmol/l aldrithiol) than under strong reducing conditions
(10mmol/l reduced dithiothreitol). It is superoxide selective over
other physiologically relevant oxidants and metabolites. Adenovirus-
mediated gene transfer is used to express cpYFP in the mitochon-
drial matrix of cells with use of the cytochrome c oxidase subunit IV
targeting sequence (mt-cpYFP) to detect mitochondrial O2
 .
Ad-mt-cpYFP was allowed to express for 36 h before assays.
Mitochondrial MP detection
Mitochondrial MP was measured using DiOC6(3) (Molecular
Probes), which is selective for the mitochondrial potentiometric
indicator of live cells. DiOC6(3) (50 nmol/l) was incubated for
30min. Mean fluorescence intensity detected by confocal micro-
scopy at 488-nm excitation was used for quantification.
Western blot analysis
Following treatment, cell and aortic extracts were collected. Proteins
were subjected to sodium dodecyl sulfate polyacrylamide gel electro-
phoresis and then transferred to a nitrocellulose membrane, then
incubated successively with 3% bovine serum albumin and different
primary antibodies: anti-SM22a (1:2000) and anti-SM-a-actin (1:1000,
both from Sigma), and anti-b-actin, Cbfa1, IKKb, IkBa, SOD1, SOD2,
and UCP2 (1:500, Santa Cruz Biotechnology, Santa Cruz, CA), and
then were incubated in IRDye700 or 800-conjugated secondary
antibody (1:20,000, Rockland, Gilbertsville, PA) for 1 h. The fluores-
cence signal was then detected using the Odyssey infrared imaging
system (LI-COR Biosciences, Lincoln, NE).
Real-time PCR analysis
Total RNA from aortic tissue or BASMCs was isolated using Trizol and
subjected to a reverse transcription system (Promega, Madison, WI).
In real-time PCR, 1 ml of the reaction mixture was used. The amount
of PCR products formed in each cycle was evaluated by SYBR Green I
fluorescence (Invitrogen, Carlsbad, CA). The forward and reverse PCR
primers based on bovine genes were: Cbfa1, 50-ATGGCGGGTAACG
ATG-30, 50-GCGGGACACCTACTCTCATAC-30; SM22a, 50-TGGTG
GAGTGGATCGTAATGC-30, 50-AGAGGTCAACGGTCTGGAACA-30;
SM-a-actin, 50-TGGCTCTGGGCTCTGTAA-30, 50-CCTCTTTTGCT
TTGTGCTT-30; and Msx2, 50-CCGCCAGAAACAGTACCTCT-30,
50-ATATCCCACTGGAGTCGCATA-30. All amplification reactions
involved use of the Mx3000 Multiplex Quantitative PCR System
(Stratagene, La Jolla, CA).
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Immunofluorescence analysis
After treatment, samples were fixed with 4% paraformaldehyde and then
rendered permeable by incubation in 0.1% Triton X-100 in 5% bovine
serum albumin–phosphate-buffered saline for 15min. They were then
incubated with the antibody against p65 or phosphorylated p65 (dilution
1:200, Santa Cruz Biotechnology) overnight and with the secondary
Alexa Fluor 488 (Invitrogen) donkey anti-rabbit IgG (dilution 1:500)
for 1h. Nuclei were labeled with Hoechst 33342 (Sigma, St Louis, MO).
Negative controls were carried out by omitting the primary antibody.
Statistical analysis
Data are expressed as mean±s.e.m. Comparisons between two
groups involved Student’s t-test, and that between more than two
groups one-way analysis of variance, and then Tukey–Kramer post
hoc testing. A Po0.05 was considered statistically significant.
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SUPPLEMENTARY MATERIAL
Figure S1. BASMCs were treated with H2O2 and/or BGP (10mmol/l)
as indicated for 7 days, and then calcium content was measured.
Figure S2. High glucose alone increased mitochondrial ROS, but
failed to induce calcification.
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